{"AllianceGenome": "6193", "HGNC": "6193", "MIM": "600173", "_id": "3718", "_version": 1, "accession": {"genomic": ["AC007201.1", "AF513860.1", "CH471106.1", "CP068259.2", "NC_000019.10", "NC_060943.1", "NG_007273.1", "U70065.1"], "protein": ["AAA17743.1", "AAA19626.1", "AAC50225.1", "AAC50226.1", "AAC50542.1", "AAC50950.1", "AAD22741.1", "AAH28068.1", "AAM44860.1", "ALQ33611.1", "ALQ33612.1", "BAG59055.1", "BAG65227.1", "EAW84637.1", "EAW84638.1", "EAW84639.1", "EAW84640.1", "NP_000206.2", "P52333.2", "XP_011526293.2", "XP_047294742.1", "XP_054176885.1", "XP_054176886.1"], "rna": ["AK296383.1", "AK304392.1", "BC028068.1", "BF512748.1", "BM561964.1", "DA405504.1", "KU178153.1", "KU178154.1", "NM_000215.4", "U08340.1", "U09607.1", "U31317.1", "U31601.1", "U57096.1", "XM_011527991.3", "XM_047438786.1", "XM_054320910.1", "XM_054320911.1", "XR_007066796.1", "XR_008485140.1"], "translation": [{"protein": "AAC50542.1", "rna": "U57096.1"}, {"protein": "BAG65227.1", "rna": "AK304392.1"}, {"protein": "AAH28068.1", "rna": "BC028068.1"}, {"protein": "NP_000206.2", "rna": "NM_000215.4"}, {"protein": "XP_054176885.1", "rna": "XM_054320910.1"}, {"protein": "ALQ33611.1", "rna": "KU178153.1"}, {"protein": "XP_047294742.1", "rna": "XM_047438786.1"}, {"protein": "AAC50226.1", "rna": "U31601.1"}, {"protein": "AAA19626.1", "rna": "U09607.1"}, {"protein": "XP_011526293.2", "rna": "XM_011527991.3"}, {"protein": "AAA17743.1", "rna": "U08340.1"}, {"protein": "XP_054176886.1", "rna": "XM_054320911.1"}, {"protein": "AAC50225.1", "rna": "U31317.1"}, {"protein": "BAG59055.1", "rna": "AK296383.1"}, {"protein": "ALQ33612.1", "rna": "KU178154.1"}]}, "alias": ["JAK-3", "JAK3_HUMAN", "JAKL", "L-JAK", "LJAK"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "definitive", "classification_date": "2020-12-18T20:05:20.841Z", "disease_label": "T-B+ severe combined immunodeficiency due to JAK3 deficiency", "gcep": "SCID-CID Gene Curation Expert Panel", "moi": "AR", "mondo": "MONDO:0010938", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_669dcacf-8423-4507-a36c-feab049737b3-2020-12-18T200520.841Z", "sop": "SOP8"}}, "ec": "2.7.10.2", "ensembl": {"gene": "ENSG00000105639", "protein": ["ENSP00000391676", "ENSP00000432511", "ENSP00000436421", "ENSP00000513006"], "transcript": ["ENST00000458235", "ENST00000526008", "ENST00000527031", "ENST00000527670", "ENST00000528293", "ENST00000528705", "ENST00000534444", "ENST00000696967", "ENST00000696968", "ENST00000696969", "ENST00000696970"], "translation": [{"protein": "ENSP00000391676", "rna": "ENST00000458235"}, {"protein": "ENSP00000432511", "rna": "ENST00000527670"}, {"protein": "ENSP00000513006", "rna": "ENST00000526008"}, {"protein": "ENSP00000436421", "rna": "ENST00000534444"}], "type_of_gene": "protein_coding"}, "entrezgene": "3718", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 37.981556359, "exp_mis": 445.254483441, "exp_syn": 204.949143015, "lof_z": 5.30120325354829, "mis_z": 3.45971033929955, "mu_lof": 3.01950959857e-06, "mu_mis": 4.6140859059e-05, "mu_syn": 2.09101996413e-05, "n_lof": 5.0, "n_mis": 296.0, "n_syn": 154.0, "p_li": 0.995863799803735, "p_null": 1.14524465678421e-10, "p_rec": 0.0041362000817402, "syn_z": 2.20629220835047}, "bp": 3375, "cds_end": 17955226, "cds_start": 17937551, "n_exons": 23, "nonpsych": {"exp_lof": 33.9686318926, "exp_mis": 402.589943603, "exp_syn": 185.090417117, "lof_z": 5.04986563224903, "mis_z": 3.50900688083163, "mu_lof": 3.01950959857e-06, "mu_mis": 4.6140859059e-05, "mu_syn": 2.09101996413e-05, "n_lof": 4.0, "n_mis": 263.0, "n_syn": 143.0, "p_li": 0.996883054765695, "p_null": 3.45977353323333e-10, "p_rec": 0.00311694488832726, "syn_z": 1.94784596700639}, "nontcga": {"exp_lof": 34.9032305438, "exp_mis": 409.594352042, "exp_syn": 188.513424454, "lof_z": 5.16003101093426, "mis_z": 3.48560971948102, "mu_lof": 3.01950959857e-06, "mu_mis": 4.6140859059e-05, "mu_syn": 2.09101996413e-05, "n_lof": 4.0, "n_mis": 268.0, "n_syn": 149.0, "p_li": 0.997581983064375, "p_null": 1.52393188401579e-10, "p_rec": 0.00241801678323225, "syn_z": 1.82219803873116}, "transcript": "ENST00000458235.1"}, "exons": [{"cdsend": 17844417, "cdsstart": 17826742, "chr": "19", "position": [[17824783, 17826910], [17830107, 17830218], [17830502, 17830620], [17831227, 17831400], [17831673, 17831798], [17832518, 17832708], [17832789, 17832929], [17834570, 17834721], [17834851, 17835003], [17835082, 17835215], [17835923, 17836051], [17837128, 17837213], [17837931, 17838063], [17838262, 17838390], [17839476, 17839663], [17840229, 17840341], [17841388, 17841546], [17841639, 17841762], [17842315, 17842610], [17843026, 17843172], [17843379, 17843491], [17843776, 17843900], [17844233, 17844430], [17847945, 17847982]], "strand": -1, "transcript": "NM_000215", "txend": 17847982, "txstart": 17824783}], "exons_hg19": [{"cdsend": 17955226, "cdsstart": 17937551, "chr": "19", "position": [[17935590, 17937719], [17940916, 17941027], [17941311, 17941429], [17942036, 17942209], [17942482, 17942607], [17943327, 17943517], [17943598, 17943738], [17945379, 17945530], [17945660, 17945812], [17945891, 17946024], [17946732, 17946860], [17947937, 17948022], [17948740, 17948872], [17949071, 17949199], [17950285, 17950472], [17951038, 17951150], [17952197, 17952355], [17952448, 17952571], [17953124, 17953419], [17953835, 17953981], [17954188, 17954300], [17954585, 17954709], [17955042, 17955239], [17958754, 17958791]], "strand": -1, "transcript": "NM_000215", "txend": 17958791, "txstart": 17935590}], "generif": [{"pubmed": 7659163, "text": "The first demonstration that JAK3 mutations underlie autosomal recessive severe combined immunodeficiency"}, {"pubmed": 7973658, "text": "JAK3 is associated with the Interleukin-2 receptor gamma-chain (IL2RG)."}, {"pubmed": 8022485, "text": "JAK3 is phosphorylated in response to stimulation of lymphocytes with IL-2"}, {"pubmed": 8022790, "text": "Cloning of human Jak3"}, {"pubmed": 11668610, "text": "mutations in severe combined immune deficiency (SCID) due to JAK3 deficiency"}, {"pubmed": 11668621, "text": "eleven novel mutations in patients with severe combined immunodeficiency-including the first patients with mutations in the kinase domain"}, {"pubmed": 12145687, "text": "In the T cell line HUT-78, JAK3 was found to be highly phosphorylated. These results suggest that SHP-1 might be involved in maintaining the IL-2R/JAK3 signaling pathway under control and point towards a role of SHP-1 in the pathogenesis of the disease."}, {"pubmed": 12207328, "text": "JAK3 is associated with a pre-phosphorylated IL-4Ralpha and CD40. This novel \"heterotrimer\" (p-IL-4Ralpha, CD40/JAK3) is functional and controls STAT3 phosphorylation and CD40 expression."}, {"pubmed": 12351625, "text": "the JH2 domain contributes to both the uninduced and ligand-induced Jak-receptor complex, where it acts as a cytokine-inducible switch to regulate signal transduction"}, {"pubmed": 12613524, "text": "newly described sequence corrects the previous published genomic sequence from Jak3 spanning introns 10 and 11 rather than identifying an insertion or translocation specific to these ALL"}, {"pubmed": 12777975, "text": "Data suggest there is no defect in the JAK/STAT pathway in the tested melanoma cell lines, and that interferon resistance must be mediated through other components."}, {"pubmed": 12794134, "text": "The Jak3 promoter is found 60 bp upstream of a large (roughly 3500 bp) intron in the nontranslated 5' protion of Jak3 mRNA; it is active in primary lymphocytes, Jurkat T cells, and NK3.3 cells, but not in COS or HeLa cells."}, {"pubmed": 14593182, "text": "A highly selective and potent JAK3 inhibitor is effective in a nonhuman primate model of transplant rejection"}, {"pubmed": 14615376, "text": "mutations all resulted in abnormal B-cell Janus kinase 3 (JAK3)-dependent interleukin-2 (IL-2)-induced signal transducer and activator of transcription-5 (STAT5) phosphorylation."}, {"pubmed": 14726805, "text": "Meta-analysis and HuGE review of genotype prevalence, gene-disease association, genetic testing, and healthcare-related. (HuGE Navigator)"}, {"pubmed": 15067075, "text": "Findings support a model in which JAK3 signaling enhances IL-10 production in monocytes/macrophages leading to down-regulation of IL-1 beta converting enzyme (ICE) activation and suppression of IL-1 beta processing and release."}, {"pubmed": 15584866, "text": "Review. Jak3 mediates signal transduction via the gamma common chain of lymphokine surface receptors. Its structural and genetic features are discussed."}, {"pubmed": 15611059, "text": "CXCL12 signaling is independent of Jak2 and Jak3"}, {"pubmed": 15831699, "text": "phosphate group on pTyr981 in the activation loop is in part coordinated by an arginine residue in the regulatory C-helix, suggesting a direct mechanism by which the active position of the C-helix is induced by phosphorylation of the activation loop"}, {"pubmed": 16153455, "text": "We conclude that Jak3 activation is predominantly restricted to ALK-positive ALCL tumors. Most likely."}, {"pubmed": 16192633, "text": "Inhibition of JAK3 signaling in colon carcinoma tumors and cell lines induces apoptosis and cell cycle arrest of colon carcinoma cells."}, {"pubmed": 16308103, "text": "JAK3 is a highly significant, prognostic immunohistochemical marker in CRC. This study proves that cDNA microarrays, plotted by a small number of genes from a few samples, are both practical and useful."}, {"pubmed": 16515549, "text": "WHI-P154, an inhibitor of Janus protein tyrosine kinase (JAK3), Hck and Syk, prevented PDGF-induced neurite outgrowth."}, {"pubmed": 16763206, "text": "IL-9/Jak3 signaling plays a significant role in the pathogenesis of ALK+ anaplastic large-cell lymphoma"}, {"pubmed": 16790275, "text": "The transforming activity of JAK3(V674A) was confirmed by its introduction into 32Dcl3-mCAT. Sequencing of the original JAK3 cDNA derived from the patient, however, failed to detect the V674A mutation."}, {"pubmed": 16825495, "text": "Loss of SHP1 enhances JAK3/STAT3 signaling and decreases proteosome degradation of JAK3 and NPM-ALK in ALK+ anaplastic large-cell lymphoma."}, {"pubmed": 16843266, "text": "Findings illustrate the biological importance of gain-of-function JAK3 mutations in leukemogenesis."}, {"pubmed": 16932349, "text": "evidence of VEGF production in cutaneous T-cell lymphoma, which is promoted by aberrant activation of Jak3 and the JNKs"}, {"pubmed": 17081797, "text": "These results suggest that oncostatin M inhibits adiponectin expression by inducing dedifferentiation of adipocytes through signaling pathways involving JAK3 and MEK, but not JAK2."}, {"pubmed": 17252020, "text": "4 types of JAK3 mutations were found in acute megakaryoblastic leukemia & transient myeloproliferative disorder patients, all in the pseudokinase domain or receptor-binding domain. I87T is in the common-gamma-subunit-binding domain."}, {"pubmed": 17456055, "text": "data suggest that both gain-, and loss-of function mutations of jak3 can be acquired in Down syndrome -transient myeloproliferative disorder /acute megakaryoblastic leukaemia (DS-TMD/AMKL)"}, {"pubmed": 17537734, "text": "a novel pathway in intestinal enterocytes in which IL-2 enhances intestinal wound repair through mechanisms involving Jak3 and its interactions with villin."}, {"pubmed": 17938255, "text": "the effect of IL-15 and IL-21, which are closely related to IL-2 and share the usage of the common gamma chain and of its JAK3-associated pathway."}, {"pubmed": 18250158, "text": "2 new Tyr phosphorylation sites within Jak3, Y904 & Y939, are conserved among Jak family proteins. Y904 and Y939 were required for optimal ATP usage by Jak3, while phosphorylation of Y939 preferentially promoted Stat5 activity in intact cells."}, {"pubmed": 18297515, "text": "review of roles of Jak2, Jak3, and MPL mutations in signal transduction and etiology of myeloid malignancies"}, {"pubmed": 18397343, "text": "the JAK3 activating mutation is an early event during leukaemogenesis in Down syndrome"}, {"pubmed": 18559588, "text": "Some of the JAK1 and JAK3 mutations may to be functional and contributes to cancer development, especially to T-ALL development."}, {"pubmed": 18633131, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 18676680, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18755984, "text": "In a series of human AMKL samples from both Down syndrome and non-Down syndrome patients, mutations were identified within KIT, FLT3, JAK2, JAK3, and MPL genes, with a higher frequency in DS than in non-DS patients."}, {"pubmed": 19012493, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19017763, "text": "Jak-3 was expressed at higher levels in patients with diabetic nephropathy than in control subjects."}, {"pubmed": 19139084, "text": "Constitutively expressed recombinant human JAK3A572V induces an aggressive, fatal, transplantable lymphoproliferative disorder of CD8(+)TCRalphabeta(+)CD44(+)CD122(+)Ly-6C(+) T cells in mice."}, {"pubmed": 19141860, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19170196, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 19248116, "text": "IL-7 stimulates chondrocyte secretion of S100A4 via activation of JAK/STAT signaling, and then S100A4 acts in an autocrine manner to stimulate MMP-13 production via RAGE."}, {"pubmed": 19282076, "text": "Genetic polymorphisms in the Jak-Stat signaling pathway are associated with an increased risk of new cardiovascular events in incident dialysis patients."}, {"pubmed": 19282076, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19385051, "text": "The JAK3/ERK pathway may play an important role in epidermal growth factor induced MMP-9 expression in SKBR3 cells."}, {"pubmed": 19423540, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19464057, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19470474, "text": "Genomic resequencing of JAK1, JAK2, JAK3, and TYK2 in 187 diagnostic samples from a high risk B-progenitor ALL cohort that had available DNA and gene expression profiling data identified mutations in JAK1, JAK2, and JAK3 in 20 patients (10.7%)."}, {"pubmed": 19531027, "text": "Data show that IL-4 receptors are functionally competent in pancreatic beta-cells and that they signal via PI3K and JAK/STAT pathways."}, {"pubmed": 19573080, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19608866, "text": "these findings support the enhancement of JAK3/STAT3 activation and cell growth in anaplastic lymphoma kinase positive - anaplastic large cell lymphoma via IL-21 signaling."}, {"pubmed": 19625176, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19692168, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19734221, "text": "Transgenic Jak3-dependent common gamma c cytokine signals are not required for naive primary CD4-positive T cell proliferation and cell cycle regulation in vitro."}, {"pubmed": 19773279, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19859091, "text": "Observational study of genetic testing. (HuGE Navigator)"}, {"pubmed": 19889552, "text": "Data suggest that an impaired IL-7/JAK3 signal may cause SCID and compromise T-cell differentiation, even if the IL-15 signal is preserved and supports NK-cell development."}, {"pubmed": 19913121, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19923221, "text": "Data indicate that ser/thr phosphorylation negatively regulates IL-2 receptor complex formation and JAK3/STAT5 activation, and that this regulation is counteracted by PP2A."}, {"pubmed": 20040389, "text": "Data show that flavones inhibited the phosphorylation of STAT6, janus kinase 3, and IL-4Ralpha, whereas IL-4 signaling mediated through type II IL-4R was unaffected by flavones."}, {"pubmed": 20138049, "text": "Generated a receptor-independent, cell-based selective screening system for specific JAK3 inhibitors, which is easily convertible to a high-throughput screening platform."}, {"pubmed": 20190194, "text": "-7Ralpha degradation depends on the activation of the IL-7 signaling effector JAK3"}, {"pubmed": 20237298, "text": "identified a common GXG signature nucleotide-binding site shared by the gamma-secretase subunit presenilin-1 C-terminal fragment (PS1-CTF), SIRT2, and Janus kinase 3"}, {"pubmed": 20339477, "text": "In renal cell carcinoma patients, a decreased proliferative response to tumor, associated with defects in JAK3/STAT5/6 expression that led to increased p27KIP1 expression and alterations in the cell cycle, was observed."}, {"pubmed": 20372811, "text": "Data show that exosomes inhibited the expression of JAK3 and phosphorylation of STAT5 in high doses in T-cells, but not JAK2, while EXO/IL-12 had much less attenuated reduction of the expression of p-STAT5."}, {"pubmed": 20406964, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20438785, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 20478313, "text": "Here, the authors report the crystal structures of TYK2, a first in class structure, and JAK3 in complex with PAN-JAK inhibitors CP-690550 and CMP-6, both of which bind in the ATP-binding cavities of both JAK isozymes."}, {"pubmed": 20568250, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20568388, "text": "Janus kinase 3 missense mutation in a child with Jacobsen syndrome."}, {"pubmed": 20628086, "text": "Observational study of gene-disease association, gene-environment interaction, and pharmacogenomic / toxicogenomic. (HuGE Navigator)"}, {"pubmed": 20697856, "text": "As for JAK3 in ATLL, a synonymous mutation was found in one case. JAK1 and JAK3 mutations are unlikely involved in the leukemogenesis of ATLL."}, {"pubmed": 20697856, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20800603, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20959405, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 21048031, "text": "Observational study of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 21095188, "text": "Data show that JAK3 silencing severely inhibited IL-8-mediated chemotaxis."}, {"pubmed": 21345943, "text": "Lyn coimmunoprecipitates with the interleukin-2 beta receptor and JAK3 proteins in human T-cell leukemia virus type 1-infected T-cells."}, {"pubmed": 21346774, "text": "malignant T cells in cutaneous T-cell lymphoma (CTCL) lesions express IL-17 and that this expression is promoted by the Jak3/Stat3 pathway."}, {"pubmed": 21414324, "text": "A high level of cell invasiveness of cancer cells can be explained for the first time by combined high JAK3/PLD2 phosphorylation and activity involving PLD2's Y415 residue, which might constitute a novel target to inhibit cancer cell invasion."}, {"pubmed": 21537335, "text": "JAK3 mutations may be associated with a more aggressive form of myeloid leukemia-Down Syndrome."}, {"pubmed": 21599579, "text": "This study defines a novel JAK3 mutation among patients with N-DS AML and demonstrates that normal individuals can also display germline JAK3 substitutions, previously proven to have oncogenic properties, in vitro and in vivo."}, {"pubmed": 21691072, "text": "Janus kinase 3 is expressed in erythrocytes, phosphorylated upon energy depletion and involved in the regulation of suicidal erythrocyte death."}, {"pubmed": 21821710, "text": "Somatic, missense mutations occurred in the N-terminal FERM (founding members: band 4.1, ezrin, radixin, and moesin) domain and induced gain of function in JAK3 in adult T-cell leukemia/lymphoma."}, {"pubmed": 21868263, "text": "JAK3 mutations are found in a subset of clear cell renal cell carcinoma patients and may be associated with its development and a greater risk of metastases"}, {"pubmed": 21969365, "text": "dominant-negative mutants of either Cullin1 or Cullin5, which lack the C terminus responsible for recruiting the E2 enzymes, were able to prevent JAK3 degradation induced by both ASB2/SKP2 and NOTCH signaling."}, {"pubmed": 21971513, "text": "Review: discuss role of JAK3 inhibitors as immunosuppressive agents in kidney transplantation."}, {"pubmed": 22039266, "text": "Data imply that IL-21-mediated signaling is critical for long-lived humoral immunity and to restore antibody responses in IL2RG/JAK3-deficient patients after hematopoietic cell transplantation."}, {"pubmed": 22130498, "text": "analysis of the biochemistry, immunological functions, and clinical significance of JAK3 [review]"}, {"pubmed": 22221142, "text": "peripheral blood lymphocytes (PBLs) of ovarian cancer patients showed lower JAK3, CD3-zeta molecules expression levels, as well as lower STAT3 and CD3-zeta phosphorylation levels than cells of control."}, {"pubmed": 22368272, "text": "Outcome modeling with CRLF2, IKZF1, JAK, and minimal residual disease in pediatric acute lymphoblastic leukemia."}, {"pubmed": 22425895, "text": "JAK3 mutations are associated with response to therapy in T-cell acute lymphoblastic leukemia."}, {"pubmed": 22705984, "text": "Data suggest that Janus kinase 3 (JAK3) may play a significant role in the pathogenesis of natural killer/T-cell lymphoma (NKTCL)."}, {"pubmed": 23012362, "text": "analysis of molecular mechanism of interactions between Jak3 and cytoskeletal proteins where tyrosine phosphorylation of the SH2 domain acted as an intramolecular switch for the interactions between Jak3 and cytoskeletal proteins"}, {"pubmed": 23238254, "text": "Data indicate that the invasive phenotype of MDA-MB-231 cells is mediated by phospholipase D2 (PLD2) under direct regulation of both Janus kinase 3 (JAK3) and tepidermal growth factor receptor (EGFR)."}, {"pubmed": 23341462, "text": "Data suggest that cross-talk occurs between cAMP/PKA and the IL-2R beta/Jak3/Stat5b cascade in T-cells."}, {"pubmed": 23384681, "text": "Hypomorphic Janus kinase 3 mutations result in a spectrum of immune defects, including partial maternal T-cell engraftment."}, {"pubmed": 23404507, "text": "analysis of the JAK-Fes-phospholipase D signaling pathway that is enhanced in highly proliferative breast cancer cells"}, {"pubmed": 23808814, "text": "no JAK3 mutations (A572V or A573V) were identified in samples of NK cell neoplasms and EBV-associated T/NK cell lymphoproliferative diseasein Japan"}, {"pubmed": 23832011, "text": "Mutations of SETBP1 and JAK3 were common recurrent secondary events presumed to be involved in tumor progression and were associated with poor clinical outcomes."}, {"pubmed": 23934551, "text": "JAK3 is a powerful regulator of the peptide transporters PEPT1 and PEPT2."}, {"pubmed": 24045942, "text": "the essential role of Jak3 in the colon where it facilitated mucosal differentiation by promoting the expression of differentiation markers and enhanced colonic barrier functions through AJ localization of beta-catenin."}, {"pubmed": 24048415, "text": "T-cell prolymphocytic leukemia is associated with a high rate of JAK1/3 mutations."}, {"pubmed": 24446122, "text": "The finding of recurrent activating JAK3 mutations in patients with T-PLL could enable the use of JAK3 inhibitors to treat patients with this unfavorable malignancy who otherwise have a very poor prognosis."}, {"pubmed": 24548303, "text": "In cervical cancer cells the phosphorylation of STAT5/JAK3 increases at low doses of IL-2 but significantly decreases at high doses."}, {"pubmed": 24674452, "text": "Report activated JAK3 variant in myelodysplastic syndromes."}, {"pubmed": 24795043, "text": "we not only characterize Jak3 interaction with Shc, but also demonstrate the molecular mechanism of intracellular regulation of Jak3 activation"}, {"pubmed": 24843152, "text": "These data indicate that JAK pseudokinases are autoinhibitory domains that hold the kinase domain inactive until receptor dimerization stimulates transition to an active state."}, {"pubmed": 24965108, "text": "in extranodal natural killer/T cell lymphomas, phosphorylated JAK3 expression does not necessarily harbor exon 13 mutations."}, {"pubmed": 25146434, "text": "that JAK3 may contribute to the pathogenesis of pediatric ALL and serve as an important therapeutic target which can be leveraged to improve outcomes for pediatric patients with ALL."}, {"pubmed": 25430085, "text": "The study reports the first patient with relapsed pediatric Early T-cell precursor acute lymphoblastic leukemia to exhibit a homozygous JAK3 activating mutation, V674A, caused by acquired uniparental disomy."}, {"pubmed": 25509109, "text": "JAK3/STAT5 signaling via IL-2 receptor is necessary to maintain the long-term expression of the high-affinity alpha beta gamma(c)-receptor of IL-2 and optimal proliferation of blood lymphocytes."}, {"pubmed": 25552479, "text": "These results suggest irreversible inhibitors of this class may be useful selective agents, both as tools to probe Jak3 biology and potentially as therapies for autoimmune diseases."}, {"pubmed": 25815310, "text": "These results do not confirm association between JAK3 polymorphisms and cardiovascular disease in rheumatoid arthritis."}, {"pubmed": 25832652, "text": "JAK inhibitor ruxolitinib (that inhibits mainly the JAK3/STAT5 pathway) affects key characteristics of human NK cells, such as cytokine-induced expansion and killing via an impaired cytokine-mediated NK cell activation"}, {"pubmed": 26082451, "text": "Activating Janus kinase 3 mutation is associated with mycosis fungoides."}, {"pubmed": 26182690, "text": "Case Report: JAK3 mutations giving rise to common variable immunodeficiency mimicking late-onset combined immunodeficiency."}, {"pubmed": 26244872, "text": "Data provide the first evidence that de-regulated Jak3/STAT3/STAT5 signalling in CTCL cells represses the expression of the gene encoding miR-22, a novel tumor suppressor miRNA."}, {"pubmed": 26248889, "text": "Letter/Case Report: ersistent rotavirus diarrhea post-transplant in a novel JAK3-SCID patient after vaccination."}, {"pubmed": 26451047, "text": "Jak3 has a role in promoting mucosal tolerance through suppressed expression and limiting activation of TLRs thereby preventing intestinal and systemic chronic low-grade inflammation and associated obesity and MetS"}, {"pubmed": 26493028, "text": "Study shows JAK3 mutations in 16% of patients with T-cell prolymphocytic leukemia which might be an important prognostic marker."}, {"pubmed": 26565811, "text": "N225K and A550V PTPN6 mutations cause loss-of-function leading to JAK3 mediated deregulation of STAT3 pathway and uncover a mechanism that tumor cells can use to control PTPN6 substrate specificity."}, {"pubmed": 26666525, "text": "This study showed that JAK3 is a powerful negative regulator of the creatine transporter SLC6A8."}, {"pubmed": 26769277, "text": "Study describes three patients with a novel deep intronic mis-splicing mutation in JAK3 as a cause of T-B+NK- severe combined immunodeficiency."}, {"pubmed": 26829670, "text": "interleukin-4 regulates hematopoietic lineage choice by activating the JAK3-STAT6 pathway, which causes dendritic-cell-specific DNA demethylation."}, {"pubmed": 26917488, "text": "Results confirm that JAK3 is mutated in T-PLL and underscore the potential therapeutical relevance of epigenetic regulator."}, {"pubmed": 26980750, "text": "we report the results of a screening for mutations in SETBP1 and JAK3 of a cohort of seventy Italian patients with juvenile myelomonocytic leukemia, identifying 11.4% of them harboring secondary mutations in these two genes and discovering two new mutations in the SKI domain of SETBP1"}, {"pubmed": 27063186, "text": "JAK3 and MCL-1 were down-regulated in patient CD8(+) T cells versus their normal counterparts, likely due to defective suppressor activity of miR-29b and miR-198 in RCC CD8(+) T cells."}, {"pubmed": 27077371, "text": "Foxp3 has a rapid turn over in Treg partly controlled at the transcriptional level by the JAK/STAT pathway"}, {"pubmed": 27297789, "text": "In natural killer/T-cell lymphoma (NKTL) as a disease model, phosphorylation of EZH2 by JAK3 promotes the dissociation of the PRC2 complex leading to decreased global histone H3 lysine 27 methylation levels."}, {"pubmed": 27436342, "text": "a causal relationship between MLH1-deficiency and incidence of oncogenic point mutations in tyrosine kinases driving cell transformation and acquired resistance to kinase-targeted cancer therapies, is reported."}, {"pubmed": 27555492, "text": "analysis of JAK3 kinetic mechanism and inhibition by tofacitinib"}, {"pubmed": 27593409, "text": "patient had a homozygote of the JAK3 mutation, and her parents were heterozygous carriers."}, {"pubmed": 27595398, "text": "JAK3 up-regulates SGLT1 activity by increasing the carrier protein abundance in the cell membrane, an effect enforcing cellular glucose uptake into activated lymphocytes and thus contributing to the immune response."}, {"pubmed": 28009988, "text": "Data indicate that phosphorylation of Janus kinase 3 (JAK3) and STAT3 transcription factor (STAT3) was inhibited by latent membrane protein 1 (LMP1)-IgG."}, {"pubmed": 28284718, "text": "frequency of JAK3 mutations in the JH2 domain was relatively low in extranodal natural killer/T-cell lymphoma, nasal type (NTCL) in contrast to a previous report; study identified novel JAK3H583Y- and JAK3G589D-activating mutations that were oncogenic and sensitive to a JAK3 inhibitor"}, {"pubmed": 28473442, "text": "JAK3 mediates smooth muscle cell proliferation and survival during injury-induced vascular remodeling."}, {"pubmed": 28821617, "text": "Jak3-mediated phosphorylation of beta-catenin suppressed EGF-mediated epithelial-mesenchymal transition and facilitated epithelial barrier functions by AJ localization of phosphorylated beta-catenin through its interactions with alpha-catenin."}, {"pubmed": 29082853, "text": "identification of activating somatic mutations in JAK2 and germline mutations in JAK3 with clinical implications"}, {"pubmed": 29187379, "text": "One-third of cases with JAK3 mutation harbor two JAK3 mutations and double JAK3 mutants show stronger signaling than single JAK3 mutants in patients with T-cell acute lymphoblastic leukemia (T-ALL)."}, {"pubmed": 29530480, "text": "JAK-1 and JAK-3 expression may play a role in the inflammatory processes in patients with ankylosing spondylitis."}, {"pubmed": 29728406, "text": "IL2RG/JAK3-deficient B cells remain intrinsically defective posttransplant despite follicular helper T-cell reconstitution. In vitro response of B cells to IL-21 is a potential biomarker for humoral immunity in patients with IL2RG/JAK3 SCID after transplantation."}, {"pubmed": 30032486, "text": "JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene."}, {"pubmed": 30129110, "text": "excreted-secreted antigens (ESA) directly influenced the expression of IL-2Rgamma, rather than the availability of IL-2 indirectly. ESA suppressed the level of Foxp3 via inhibiting IL-2Rgamma/JAK3/Stats signaling pathway in EL4 cells."}, {"pubmed": 30777857, "text": "Germline mutation in JAK3 gene is associated with Racial Disparities in Head and Neck Cancer."}, {"pubmed": 31002364, "text": "The present results revealed that the JAK3/STAT3 oncogenic pathway and PRDM1 expression could stratify clinicopathologic features of extranodal NK/Tcell lymphoma, nasal type (ENNK/TNT)."}, {"pubmed": 31383643, "text": "Somatic JAK3 mutations in NK-cell enteropathy: histologic and mutational profiles."}, {"pubmed": 31393896, "text": "Single nucleotide polymorphisms of the genes IL-2, IL-2RB, and JAK3 in patients with cutaneous leishmaniasis caused by Leishmania (V.) guyanensis in Manaus, Amazonas, Brazil."}, {"pubmed": 31492675, "text": "Here we show that CRISPR/Cas9-mediated inactivation of Suz12 cooperates with mutant JAK3 to drive T-cell transformation and T-cell acute lymphoblastic leukemia development"}, {"pubmed": 31545408, "text": "High JAK3 expression is associated with peripheral Tcell lymphoma expressing the ITKSYK fusion gene."}, {"pubmed": 31879743, "text": "JAK3 facilitates the migration of breast cancer cells by store-operated calcium channel"}, {"pubmed": 32051510, "text": "A Targeted Quantitative Proteomic Method Revealed a Substantial Reprogramming of Kinome during Melanoma Metastasis."}, {"pubmed": 32215911, "text": "Frontal fibrosing alopecia shows robust T helper 1 and Janus kinase 3 skewing."}, {"pubmed": 32570038, "text": "JAK3 is a potential biomarker and associated with immune infiltration in kidney renal clear cell carcinoma."}, {"pubmed": 32639993, "text": "Kinome capture sequencing of high-grade serous ovarian carcinoma reveals novel mutations in the JAK3 gene."}, {"pubmed": 32743766, "text": "Malignant struma ovarii: next-generation sequencing of six cases revealed Nras, Braf, and Jak3 mutations."}, {"pubmed": 32877908, "text": "JAK1 rs310241 and JAK3 rs3008 Genotypes May Increase Susceptibility to Psoriasis: A Case Control Study."}, {"pubmed": 32921793, "text": "Atypical immune phenotype in severe combined immunodeficiency patients with novel mutations in IL2RG and JAK3."}, {"pubmed": 33040328, "text": "Whole-exome sequencing of T(-) B(+) severe combined immunodeficiency in Egyptian infants, JAK3 predominance and novel variants."}, {"pubmed": 33083484, "text": "JAK3 and TYK2 Serve as Prognostic Biomarkers and Are Associated with Immune Infiltration in Stomach Adenocarcinoma."}, {"pubmed": 33329590, "text": "RNA Sequencing Keloid Transcriptome Associates Keloids With Th2, Th1, Th17/Th22, and JAK3-Skewing."}, {"pubmed": 33980892, "text": "Generation of a chemical genetic model for JAK3."}, {"pubmed": 34061303, "text": "STAT3 activation in thymic epithelial tumors: correlation with cyclin D1, JAK3, and clinical behavior."}, {"pubmed": 35411095, "text": "JAK3 mutations and mitochondrial apoptosis resistance in T-cell acute lymphoblastic leukemia."}, {"pubmed": 36100323, "text": "Prognostic value of JAK3 promoter methylation and mRNA expression in clear cell renal cell carcinoma."}, {"pubmed": 36291730, "text": "Zebrafish Model of Severe Combined Immunodeficiency (SCID) Due to JAK3 Mutation."}, {"pubmed": 37830594, "text": "New JAK3-INSL3 Fusion Transcript-An Oncogenic Event in Cutaneous T-Cell Lymphoma."}, {"pubmed": 37876297, "text": "Dependence of peripheral T-cell lymphoma on constitutively activated JAK3: Implication for JAK3 inhibition as a therapeutic approach."}, {"pubmed": 38095643, "text": "Conjoint research of WGCNA, single-cell transcriptome and structural biology reveals the potential targets of IDD development and treatment and JAK3 involvement."}, {"pubmed": 38474223, "text": "Janus Kinase 3 (JAK3): A Critical Conserved Node in Immunity Disrupted in Immune Cell Cancer and Immunodeficiency."}, {"pubmed": 38598033, "text": "Omenn Syndrome in Two Infants with Different Hypomorphic Variants in Janus Kinase 3."}], "genomic_pos": {"chr": "19", "end": 17848071, "ensemblgene": "ENSG00000105639", "start": 17824780, "strand": -1}, "genomic_pos_hg19": {"chr": "19", "end": 17958880, "start": 17935589, "strand": -1}, "go": {"BP": [{"evidence": "IEA", "gocategory": "BP", "id": "GO:0002250", "qualifier": "involved_in", "term": "adaptive immune response"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0002731", "qualifier": "involved_in", "term": "negative regulation of dendritic cell cytokine production"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006468", "pubmed": 8022790, "qualifier": "involved_in", "term": "protein phosphorylation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0007167", "qualifier": "involved_in", "term": "enzyme-linked receptor protein signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0007259", "qualifier": "involved_in", "term": "cell surface receptor signaling pathway via JAK-STAT"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0007260", "pubmed": 19290934, "qualifier": "involved_in", "term": "tyrosine phosphorylation of STAT protein"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0018108", "qualifier": "involved_in", "term": "peptidyl-tyrosine phosphorylation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0019221", "qualifier": "involved_in", "term": "cytokine-mediated signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0030154", "qualifier": "involved_in", "term": "cell differentiation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0030183", "qualifier": "involved_in", "term": "B cell differentiation"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0032693", "qualifier": "involved_in", "term": "negative regulation of interleukin-10 production"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0032695", "qualifier": "involved_in", "term": "negative regulation of interleukin-12 production"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0035556", "qualifier": "involved_in", "term": "intracellular signal transduction"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0035556", "qualifier": "involved_in", "term": "intracellular signal transduction"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035723", "pubmed": 7568001, "qualifier": "involved_in", "term": "interleukin-15-mediated signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035771", "pubmed": 7538655, "qualifier": "involved_in", "term": "interleukin-4-mediated signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0038110", "pubmed": 7973659, "qualifier": "involved_in", "term": "interleukin-2-mediated signaling pathway"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0038110", "qualifier": "involved_in", "term": "interleukin-2-mediated signaling pathway"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0038113", "pubmed": 18829468, "qualifier": "involved_in", "term": "interleukin-9-mediated signaling pathway"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0042981", "qualifier": "involved_in", "term": "regulation of apoptotic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0043029", "qualifier": "involved_in", "term": "T cell homeostasis"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0043029", "pubmed": 19290934, "qualifier": "involved_in", "term": "T cell homeostasis"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0045087", "qualifier": "involved_in", "term": "innate immune response"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045221", "qualifier": "involved_in", "term": "negative regulation of FasL production"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0045626", "qualifier": "involved_in", "term": "negative regulation of T-helper 1 cell differentiation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0046425", "pubmed": 19290934, "qualifier": "involved_in", "term": "regulation of receptor signaling pathway via JAK-STAT"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0050868", "qualifier": "involved_in", "term": "negative regulation of T cell activation"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0060397", "qualifier": "involved_in", "term": "growth hormone receptor signaling pathway via JAK-STAT"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0060397", "pubmed": 19290934, "qualifier": "involved_in", "term": "growth hormone receptor signaling pathway via JAK-STAT"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0070232", "qualifier": "involved_in", "term": "regulation of T cell apoptotic process"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:0070244", "qualifier": "involved_in", "term": "negative regulation of thymocyte apoptotic process"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0070669", "pubmed": 9973401, "qualifier": "involved_in", "term": "response to interleukin-2"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0070670", "pubmed": [7538655, 7594533], "qualifier": "involved_in", "term": "response to interleukin-4"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0070672", "pubmed": 7594533, "qualifier": "involved_in", "term": "response to interleukin-15"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0071104", "pubmed": 7594533, "qualifier": "involved_in", "term": "response to interleukin-9"}], "CC": [{"evidence": "TAS", "gocategory": "CC", "id": "GO:0005768", "qualifier": "located_in", "term": "endosome"}, {"evidence": "IBA", "gocategory": "CC", "id": "GO:0005829", "qualifier": "is_active_in", "term": "cytosol"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005829", "qualifier": "located_in", "term": "cytosol"}, {"evidence": "IEA", "gocategory": "CC", "id": "GO:0005856", "qualifier": "located_in", "term": "cytoskeleton"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IC", "gocategory": "CC", "id": "GO:0019897", "pubmed": 7973658, "qualifier": "is_active_in", "term": "extrinsic component of plasma membrane"}, {"evidence": "IC", "gocategory": "CC", "id": "GO:0031234", "pubmed": [7973659, 18829468], "qualifier": "is_active_in", "term": "extrinsic component of cytoplasmic side of plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0031234", "pubmed": 7568001, "qualifier": "is_active_in", "term": "extrinsic component of cytoplasmic side of plasma membrane"}], "MF": [{"category": "MF", "evidence": "IDA", "id": "GO:0004713", "pubmed": [7973658, 18829468], "qualifier": "enables", "term": "protein tyrosine kinase activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0004713", "pubmed": 18250158, "qualifier": "enables", "term": "protein tyrosine kinase activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0004713", "qualifier": "enables", "term": "protein tyrosine kinase activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0004713", "qualifier": "enables", "term": "protein tyrosine kinase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0004715", "qualifier": "enables", "term": "non-membrane spanning protein tyrosine kinase activity"}, {"category": "MF", "evidence": "IBA", "id": "GO:0005131", "qualifier": "enables", "term": "growth hormone receptor binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": [9045636, 25852190, 32707033], "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IEA", "id": "GO:0005524", "qualifier": "enables", "term": "ATP binding"}, {"category": "MF", "evidence": "IPI", "id": "GO:0019903", "pubmed": 11909529, "qualifier": "enables", "term": "protein phosphatase binding"}]}, "homologene": {"genes": [[7955, 561370], [8364, 100135373], [9031, 395845], [9544, 720040], [9598, 748892], [9606, 3718], [9615, 610004], [9913, 538276], [10090, 16453], [10116, 25326]], "id": 181}, "interpro": [{"desc": "FERM domain", "id": "IPR000299", "short_desc": "FERM_domain"}, {"desc": "Protein kinase domain", "id": "IPR000719", "short_desc": "Prot_kinase_dom"}, {"desc": "SH2 domain", "id": "IPR000980", "short_desc": "SH2"}, {"desc": "Serine-threonine/tyrosine-protein kinase, catalytic domain", "id": "IPR001245", "short_desc": "Ser-Thr/Tyr_kinase_cat_dom"}, {"desc": "Tyrosine-protein kinase, active site", "id": "IPR008266", "short_desc": "Tyr_kinase_AS"}, {"desc": "Protein kinase-like domain superfamily", "id": "IPR011009", "short_desc": "Kinase-like_dom_sf"}, {"desc": "PH-like domain superfamily", "id": "IPR011993", "short_desc": "PH-like_dom_sf"}, {"desc": "Tyrosine-protein kinase, non-receptor Jak/Tyk2", "id": "IPR016251", "short_desc": "Tyr_kinase_non-rcpt_Jak/Tyk2"}, {"desc": "Protein kinase, ATP binding site", "id": "IPR017441", "short_desc": "Protein_kinase_ATP_BS"}, {"desc": "Band 4.1 domain", "id": "IPR019749", "short_desc": "Band_41_domain"}, {"desc": "Tyrosine-protein kinase, catalytic domain", "id": "IPR020635", "short_desc": "Tyr_kinase_cat_dom"}, {"desc": "Tyrosine-protein kinase, non-receptor Jak3", "id": "IPR020775", "short_desc": "Tyr_kinase_non-rcpt_Jak3"}, {"desc": "SH2 domain superfamily", "id": "IPR036860", "short_desc": "SH2_dom_sf"}, {"desc": "JAK, FERM F2 lobe domain", "id": "IPR041046", "short_desc": "FERM_F2"}, {"desc": "FERM F1 lobe ubiquitin-like domain", "id": "IPR041155", "short_desc": "FERM_F1"}, {"desc": "JAK1-3/TYK2, pleckstrin homology-like domain", "id": "IPR041381", "short_desc": "JAK1-3/TYK2_PHL_dom"}], "ipi": ["IPI00002773", "IPI00219418"], "map_location": "19p13.11", "name": "Janus kinase 3", "other_names": ["Janus kinase 3 (a protein tyrosine kinase, leukocyte)", "leukocyte Janus kinase", "tyrosine-protein kinase JAK3"], "pantherdb": {"HGNC": "6193", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "99928", "ortholog_type": "LDO", "panther_family": "PTHR45807", "taxid": 10090, "uniprot_kb": "Q62137"}, {"RGD": "2940", "ortholog_type": "LDO", "panther_family": "PTHR45807", "taxid": 10116, "uniprot_kb": "Q63272"}, {"ZFIN": "ZDB-GENE-070725-4", "ortholog_type": "LDO", "panther_family": "PTHR45807", "taxid": 7955, "uniprot_kb": "B0V237"}, {"FlyBase": "FBgn0004864", "ortholog_type": "LDO", "panther_family": "PTHR45807", "taxid": 7227, "uniprot_kb": "Q24592"}], "uniprot_kb": "P52333"}, "pathway": {"biocarta": [{"id": "her2pathway", "name": "role of erbb2 in signal transduction and oncology"}, {"id": "il2pathway", "name": "il 2 signaling pathway"}, {"id": "il2rbpathway", "name": "il-2 receptor beta chain in t cell activation"}, {"id": "il4pathway", "name": "il 4 signaling pathway"}, {"id": "il6pathway", "name": "il 6 signaling pathway"}, {"id": "il7pathway", "name": "il-7 signal transduction"}, {"id": "stat3pathway", "name": "stat3 signaling pathway"}], "kegg": [{"id": "hsa04062", "name": "Chemokine signaling pathway - Homo sapiens (human)"}, {"id": "hsa04151", "name": "PI3K-Akt signaling pathway - Homo sapiens (human)"}, {"id": "hsa04217", "name": "Necroptosis - Homo sapiens (human)"}, {"id": "hsa04550", "name": "Signaling pathways regulating pluripotency of stem cells - Homo sapiens (human)"}, {"id": "hsa04630", "name": "JAK-STAT signaling pathway - Homo sapiens (human)"}, {"id": "hsa04658", "name": "Th1 and Th2 cell differentiation - Homo sapiens (human)"}, {"id": "hsa04659", "name": "Th17 cell differentiation - Homo sapiens (human)"}, {"id": "hsa05161", "name": "Hepatitis B - Homo sapiens (human)"}, {"id": "hsa05162", "name": "Measles - Homo sapiens (human)"}, {"id": "hsa05166", "name": "Human T-cell leukemia virus 1 infection - Homo sapiens (human)"}, {"id": "hsa05169", "name": "Epstein-Barr virus infection - Homo sapiens (human)"}, {"id": "hsa05200", "name": "Pathways in cancer - Homo sapiens (human)"}, {"id": "hsa05203", "name": "Viral carcinogenesis - Homo sapiens (human)"}, {"id": "hsa05223", "name": "Non-small cell lung cancer - Homo sapiens (human)"}, {"id": "hsa05340", "name": "Primary immunodeficiency - Homo sapiens (human)"}], "netpath": [{"id": "Pathway_IL-7", "name": "IL-7"}, {"id": "Pathway_IL2", "name": "IL2"}, {"id": "Pathway_IL4", "name": "IL4"}, {"id": "Pathway_IL9", "name": "IL9"}, {"id": "Pathway_KitReceptor", "name": "KitReceptor"}, {"id": "Pathway_Leptin", "name": "Leptin"}, {"id": "Pathway_TCR", "name": "TCR"}], "pid": [{"id": "cd40_pathway", "name": "CD40/CD40L signaling"}, {"id": "il2_1pathway", "name": "IL2-mediated signaling events"}, {"id": "il2_pi3kpathway", "name": "IL2 signaling events mediated by PI3K"}, {"id": "il2_stat5pathway", "name": "IL2 signaling events mediated by STAT5"}, {"id": "il4_2pathway", "name": "IL4-mediated signaling events"}, {"id": "shp2_pathway", "name": "SHP2 signaling"}, {"id": "tcptp_pathway", "name": "Signaling events mediated by TCPTP"}], "reactome": [{"id": "R-HSA-1266695", "name": "Interleukin-7 signaling"}, {"id": "R-HSA-1266695", "name": "Interleukin-7 signaling"}, {"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-1280215", "name": "Cytokine Signaling in Immune system"}, {"id": "R-HSA-162582", "name": "Signal Transduction"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-168256", "name": "Immune System"}, {"id": "R-HSA-201556", "name": "Signaling by ALK"}, {"id": "R-HSA-449147", "name": "Signaling by Interleukins"}, {"id": "R-HSA-449147", "name": "Signaling by Interleukins"}, {"id": "R-HSA-451927", "name": "Interleukin-2 family signaling"}, {"id": "R-HSA-451927", "name": "Interleukin-2 family signaling"}, {"id": "R-HSA-512988", "name": "Interleukin-3, Interleukin-5 and GM-CSF signaling"}, {"id": "R-HSA-5663205", "name": "Infectious disease"}, {"id": "R-HSA-5673001", "name": "RAF/MAP kinase cascade"}, {"id": "R-HSA-5683057", "name": "MAPK family signaling cascades"}, {"id": "R-HSA-5684996", "name": "MAPK1/MAPK3 signaling"}, {"id": "R-HSA-6785807", "name": "Interleukin-4 and Interleukin-13 signaling"}, {"id": "R-HSA-8854691", "name": "Interleukin-20 family signaling"}, {"id": "R-HSA-8983432", "name": "Interleukin-15 signaling"}, {"id": "R-HSA-8983432", "name": "Interleukin-15 signaling"}, {"id": "R-HSA-8985947", "name": "Interleukin-9 signaling"}, {"id": "R-HSA-9006934", "name": "Signaling by Receptor Tyrosine Kinases"}, {"id": "R-HSA-9020558", "name": "Interleukin-2 signaling"}, {"id": "R-HSA-9020958", "name": "Interleukin-21 signaling"}, {"id": "R-HSA-912526", "name": "Interleukin receptor SHC signaling"}, {"id": "R-HSA-9679191", "name": "Potential therapeutics for SARS"}, {"id": "R-HSA-9679506", "name": "SARS-CoV Infections"}, {"id": "R-HSA-9824446", "name": "Viral Infection Pathways"}], "wikipathways": [{"id": "WP205", "name": "IL-7 signaling pathway"}, {"id": "WP22", "name": "IL-9 signaling pathway"}, {"id": "WP2374", "name": "Oncostatin M Signaling Pathway"}, {"id": "WP3929", "name": "Chemokine signaling pathway"}, {"id": "WP3932", "name": "Focal Adhesion-PI3K-Akt-mTOR-signaling pathway"}, {"id": "WP395", "name": "IL-4 signaling pathway"}, {"id": "WP4172", "name": "PI3K-Akt signaling pathway"}, {"id": "WP4255", "name": "Non-small cell lung cancer"}, {"id": "WP4337", "name": "ncRNAs involved in STAT3 signaling in hepatocellular carcinoma"}, {"id": "WP4538", "name": "Regulatory circuits of the STAT3 signaling pathway"}, {"id": "WP4666", "name": "Hepatitis B infection"}, {"id": "WP49", "name": "IL-2 signaling pathway"}]}, "pdb": ["1YVJ", "3LXK", "3LXL", "3PJC", "3ZC6", "3ZEP", "4HVD", "4HVG", "4HVH", "4HVI", "4I6Q", "4QPS", "4QT1", "4RIO", "4V0G", "4Z16", "5LWM", "5LWN", "5TOZ", "5TTS", "5TTU", "5TTV", "5VO6", "5W86", "5WFJ", "6AAK", "6DA4", "6DB3", "6DB4", "6DUD", "6GL9", "6GLA", "6GLB", "6HZV", "6NY4", "7APF", "7APG", "7C3N", "7Q6H", "7UYV", "8EXM"], "pfam": ["PF07714", "PF17887", "PF18377", "PF18379"], "pharmgkb": "PA29990", "pharos": {"target_id": 949, "tdl": "Tclin"}, "pir": "A55747", "prosite": ["PS50011", "PS50057"], "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF251715", "relationship": "is"}, {"id": "GNF251716", "relationship": "is"}, {"id": "GNF251717", "relationship": "is"}, {"id": "GNF251718", "relationship": "is"}], "GNF_hs-ORFeome1_1_reads": {"id": "GNF163258", "relationship": "is"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF085155", "relationship": "is"}, {"id": "GNF085156", "relationship": "is"}, {"id": "GNF085157", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF052573", "relationship": "is"}, {"id": "GNF057341", "relationship": "is"}, {"id": "GNF072401", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF071515", "relationship": "is"}, {"id": "GNF071516", "relationship": "is"}], "GNF_hs-pkinase_IDT-siRNA": [{"id": "GNF165272", "relationship": "is"}, {"id": "GNF165273", "relationship": "is"}, {"id": "GNF165274", "relationship": "is"}, {"id": "GNF165275", "relationship": "is"}], "GNF_hs_LentiORF-HA-MYC": {"id": "GNF283147", "relationship": "is"}, "GNF_hs_LentiORF-Jred": {"id": "GNF284074", "relationship": "is"}, "GNF_mm+hs-MGC": {"id": "GNF007287", "relationship": "is"}, "GNF_mm+hs_RetroCDNA": {"id": "GNF238504", "relationship": "is"}, "Invitrogen_IVTHSSIPKv2": [{"id": "GNF324750", "relationship": "is"}, {"id": "GNF324751", "relationship": "is"}], "NIBRI_hs-Secretome_pDEST": {"id": "GNF339103", "relationship": "is"}, "NOVART_hs-genome_siRNA": [{"id": "GNF092989", "relationship": "is"}, {"id": "GNF132687", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000019.10", "NC_060943.1", "NG_007273.1"], "protein": ["NP_000206.2", "XP_011526293.2", "XP_047294742.1", "XP_054176885.1", "XP_054176886.1"], "rna": ["NM_000215.4", "XM_011527991.3", "XM_047438786.1", "XM_054320910.1", "XM_054320911.1", "XR_007066796.1", "XR_008485140.1"], "translation": [{"protein": "NP_000206.2", "rna": "NM_000215.4"}, {"protein": "XP_054176885.1", "rna": "XM_054320910.1"}, {"protein": "XP_047294742.1", "rna": "XM_047438786.1"}, {"protein": "XP_011526293.2", "rna": "XM_011527991.3"}, {"protein": "XP_054176886.1", "rna": "XM_054320911.1"}]}, "reporter": {"HG-U133_Plus_2": ["207187_at", "211108_s_at", "211109_at", "227677_at"], "HG-U95Av2": ["1547_at", "2005_s_at", "2006_at", "2007_g_at"], "HG-U95B": "46152_at", "HTA-2_0": "TC19001280.hg.1", "HuEx-1_0": "3854627", "HuGene-1_1": "8035351", "HuGene-2_1": "16870274"}, "summary": "The protein encoded by this gene is a member of the Janus kinase (JAK) family of tyrosine kinases involved in cytokine receptor-mediated intracellular signal transduction. It is predominantly expressed in immune cells and transduces a signal in response to its activation via tyrosine phosphorylation by interleukin receptors. Mutations in this gene are associated with autosomal SCID (severe combined immunodeficiency disease). [provided by RefSeq, Jul 2008].", "symbol": "JAK3", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1334292"}, "unigene": "Hs.515247", "uniprot": {"Swiss-Prot": "P52333", "TrEMBL": "A0A0S2Z4R7"}, "wikipedia": {"url_stub": "Janus kinase 3"}}